| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |